Thymidine enhancement of 1-beta-d-arabinofuranosylcytosine activity for mouse EL4 tumors.
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D003561:Cytarabine / Q000008:administration & dosage* / Q000494:pharmacology; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D066298:In Vitro Techniques; D051379:Mice; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D013936:Thymidine / Q000008:administration & dosage* / Q000494:pharmacology; D013945:Thymoma / Q000188:drug therapy* / Q000473:pathology; D014185:Transplantation, Isogeneic
D003561:Cytarabine; D013936:Thymidine